Eyeing Stem Cell Therapies for Vision Loss
More than seven million people in the US struggle to see. While most are not completely blind, they have difficulty with, or simply can't do, daily tasks most of us…
Masayo Takahashi – 2015 Winner of Ogawa-Yamanaka Stem Cell Prize
Dr Masayo Takahashi from the RIKEN center in Japan received the prestigious 2015 Ogawa-Yamanaka Prize for developing a human induced pluripotent stem (iPS) cell therapy to treat a debilitating eye…
A Stem Cell-Based Clinical Trial for Retinitis Pigmentosa: Henry Klassen, UC Irvine
Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. In this video,…
A Stem Cell-Based Therapy for Retinitis Pigmentosa: The Patient’s Perspective
Retinitis pigmentosa (RP) is a genetic disease that gradually destroys the light-sensing nerve cells, called photoreceptors, located in the retina at the back of the eye. In this video, Rosalinda…
Mark Humayun, USC – CIRM Stem Cell #SciencePitch
Produced by the University of Southern California
Webinar: Focus on the Eye
Presentations from FDA and Leading Experts May 2, 2012 The Webinar was held on May 2, 2012 Click here to watch and listen to a recording of the webinar. Click…
Blindness: Advancing Stem Cell Therapies – 2011 CIRM Grantee Meeting
Dennis Clegg speaks at the 2011 CIRM Grantee Meeting about the development of a stem-cell based therapy for macular degeneration, the leading cause of blindness in the elderly. Clegg is…
Cures through Collaboration: Funding a Team Approach to Disease Research
Both the Guthy-Jackson Charitable Foundation (GJCF) and the California Institute for Regenerative Medicine (CIRM) share a similar vision for funding a team approach to disease research. When Victoria Jackson's daughter,…
